X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (80) 80
Publication (30) 30
Newspaper Article (7) 7
Book / eBook (1) 1
Book Chapter (1) 1
Magazine Article (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41) 41
female (32) 32
hypertension (32) 32
index medicus (32) 32
male (32) 32
aged (28) 28
middle aged (28) 28
article (27) 27
hypertension - drug therapy (23) 23
antihypertensive agents - therapeutic use (21) 21
double-blind method (18) 18
peripheral vascular disease (18) 18
prevention (17) 17
risk factors (17) 17
lipid-lowering treatment (16) 16
medicine, general & internal (16) 16
mortality (16) 16
risk (15) 15
abridged index medicus (14) 14
clinical trials (14) 14
diuretics (12) 12
research (12) 12
cardiac & cardiovascular systems (11) 11
chlorthalidone - therapeutic use (11) 11
heart failure (11) 11
amlodipine - therapeutic use (10) 10
drug therapy (10) 10
follow-up studies (10) 10
chlorthalidone (9) 9
heart attack (9) 9
lisinopril - therapeutic use (9) 9
outcomes (9) 9
stroke (9) 9
treatment outcome (9) 9
antihypertensive drugs (8) 8
blood pressure (8) 8
blood-pressure (8) 8
cardiovascular (8) 8
heart attacks (8) 8
hypertension - complications (8) 8
myocardial infarction - prevention & control (8) 8
african americans (7) 7
angiotensin-converting enzyme inhibitors - therapeutic use (7) 7
calcium channel blockers - therapeutic use (7) 7
cardiovascular disease (7) 7
disease (7) 7
health aspects (7) 7
hypolipidemic agents - therapeutic use (7) 7
incidence (7) 7
aged, 80 and over (6) 6
allhat (6) 6
cardiovascular diseases (6) 6
diuretics - therapeutic use (6) 6
dosage and administration (6) 6
prognosis (6) 6
therapy (6) 6
amlodipine (5) 5
antihypertensive agents - adverse effects (5) 5
blood pressure control (5) 5
cardiovascular diseases - prevention & control (5) 5
cardiovascular-disease (5) 5
care and treatment (5) 5
converting-enzyme-inhibitor (5) 5
doxazosin - therapeutic use (5) 5
evaluation (5) 5
health risk assessment (5) 5
heart-attack trial (5) 5
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (5) 5
hypertension - ethnology (5) 5
pravastatin - therapeutic use (5) 5
united states (5) 5
adult (4) 4
analysis (4) 4
anticholesteremic agents (4) 4
association (4) 4
attack trial allhat (4) 4
blood pressure - drug effects (4) 4
calcium-channel blocker (4) 4
cardiovascular diseases - epidemiology (4) 4
cardiovascular events (4) 4
chlorthalidone - adverse effects (4) 4
cholesterol (4) 4
coronary disease - prevention & control (4) 4
diabetes (4) 4
failure (4) 4
follow-up (4) 4
heart failure - prevention & control (4) 4
hypercholesterolemia - drug therapy (4) 4
hypertension - mortality (4) 4
hypertension control (4) 4
hypertensive patients (4) 4
lipids - blood (4) 4
lisinopril (4) 4
major cardiovascular events (4) 4
management (4) 4
metaanalysis (4) 4
patient outcomes (4) 4
pravastatin (4) 4
prevalence (4) 4
proportional hazards models (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation: Cardiovascular Quality and Outcomes, ISSN 1941-7713, 05/2009, Volume 2, Issue 3, pp. 236 - 240
Journal Article
Circulation. Cardiovascular quality and outcomes, ISSN 1941-7713, 5/2009, Volume 2, Issue 3, pp. 236 - 240
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2009, Volume 54, Issue 22, pp. 2023 - 2031
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 5/2015, Volume 63, Issue 5, pp. 1045 - 1047
Journal Article
Circulation, ISSN 0009-7322, 11/2008, Volume 118, Issue 22, pp. 2259 - 2267
Background-Heart failure (HF) developing in hypertensive patients may occur with preserved or reduced left ventricular ejection fraction (PEF [>= 50%] or REF... 
Angiotensin-converting enzyme inhibitors | Heart failure | Hypertension | Calcium channel blockers | Diuretics | Antihypertensive agents | Ventricular ejection fraction | heart failure | POPULATION | angiotensin-converting enzyme inhibitors | CARDIAC & CARDIOVASCULAR SYSTEMS | calcium channel blockers | PROGNOSIS | ALLHAT | antihypertensive agents | MECHANISMS | SYSTOLIC FUNCTION | PREVALENCE | DIASTOLIC DYSFUNCTION | CARDIOVASCULAR HEALTH | COMMUNITY | diuretics | ventricular ejection fraction | OLMSTED COUNTY | PERIPHERAL VASCULAR DISEASE | hypertension | Myocardial Infarction - epidemiology | Myocardial Infarction - mortality | Prognosis | United States | Humans | Middle Aged | Adrenergic alpha-Antagonists - therapeutic use | Hypertension - drug therapy | Male | Coronary Disease - mortality | Heart Failure - prevention & control | Doxazosin - therapeutic use | Female | Hypertension - mortality | Heart Failure - epidemiology | National Heart, Lung, and Blood Institute (U.S.) | Double-Blind Method | Risk Assessment | Stroke Volume - physiology | Survivors | Stroke Volume - drug effects | Antihypertensive Agents - therapeutic use | Hypertension - physiopathology | Amlodipine - therapeutic use | Coronary Disease - prevention & control | Survival Analysis | Hypertension - complications | Aged | Prevention | Care and treatment | Patient outcomes | Heart ventricle, Left | Physiological aspects | Antihypertensive drugs | Research | Cardiac output | Heart attack
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 04/2018, Volume 31, Issue 5, pp. 609 - 614
Abstract BACKGROUND Impaired renal function is a risk factor for cardiovascular disease, end-stage renal disease (ESRD), and mortality. The impact of... 
ESRD | Hypertension | EGFR change | Antihypertensive medications | Mortality | Blood pressure | CHD | blood pressure | LIPID-LOWERING TREATMENT | KIDNEY-FUNCTION DECLINE | RISK | eGFR change | GLOMERULAR-FILTRATION-RATE | antihypertensive medications | DISEASE | mortality | PERIPHERAL VASCULAR DISEASE | hypertension | Original Contributions | Editor's Choice
Journal Article
Journal Article
Journal Article
Hypertension, ISSN 0194-911X, 05/2012, Volume 59, Issue 5, pp. 926 - 933
Concerns exist that diuretic-induced changes in serum potassium may have adverse effects in hypertensive patients. The Antihypertensive and Lipid-Lowering... 
Diuretic | Hypertension | Calcium-channel blocker | Hypokalemia | Angiotensin-converting enzyme inhibitor | Hyperkalemia | CARDIOVASCULAR EVENTS | hyperkalemia | ALLHAT | SERUM POTASSIUM | RISK | diuretic | BLOOD-PRESSURE | STROKE | hypokalemia | angiotensin-converting enzyme inhibitor | DISEASE | PERIPHERAL VASCULAR DISEASE | calcium-channel blocker | INHIBITOR | hypertension | DIURETICS | BLOCKER | Myocardial Infarction - mortality | Prospective Studies | Blood Chemical Analysis | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Hypertension - drug therapy | Male | Incidence | Dose-Response Relationship, Drug | Hypokalemia - chemically induced | Lisinopril - adverse effects | Cardiovascular Diseases - mortality | Female | Hypertension - mortality | Hypertension - diagnosis | Amlodipine - administration & dosage | Hyperkalemia - mortality | Lisinopril - administration & dosage | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Amlodipine - adverse effects | Survival Rate | Treatment Outcome | Chlorthalidone - adverse effects | Antihypertensive Agents - adverse effects | Chlorthalidone - administration & dosage | Hyperkalemia - chemically induced | Hypokalemia - epidemiology | Aged | Myocardial Infarction - prevention & control
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 01/2019, Volume 73, Issue 3, pp. 317 - 335
The accurate measurement of blood pressure (BP) is essential for the diagnosis and management of hypertension. Restricted use of mercury devices, increased use... 
blood pressure | hypertension | measurement | CARDIAC & CARDIOVASCULAR SYSTEMS
Journal Article
The Journal of Clinical Hypertension, ISSN 1524-6175, 04/2019, Volume 21, Issue 4, pp. 451 - 459
Achieving blood pressure (BP) control is associated with lower cardiovascular disease (CVD) risk, but less is known about CVD risk associated with sustained BP... 
blood pressure control | hypertension | systolic blood pressure | TRIAL | VARIABILITY | LIPID-LOWERING TREATMENT | MANAGEMENT | BARRIERS | PERIPHERAL VASCULAR DISEASE | ADHERENCE | Heart failure | Prevention | Stroke (Disease) | Hypertension | Analysis | Mortality | Blood pressure | Health aspects | Heart attack
Journal Article